Early research (Phase 1)Ended earlyNCT04209465
What this trial is testing
BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.
Who this might be right for
Solid Tumor
Black Diamond Therapeutics, Inc. 91
Showing 20 of 0 results